RRX-001
RRX-001 (RRX001) is a novel NO and hypoxia mediated anticancer agent with with epigenetic and immunologic activity.
Product Specifications
CAS Number
925206-65-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
268.023
Molecular Formula
C5H6BrN3O5
Notes
Research use only, not for human use.
Receptor
Other Targets
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb1648345-01 10 µg
Recombinant Human Interleukin-12 Subunit β/IL-12 p40/IL-12B
Sign In for Pricing
View Details orb1648345-02 50 µg
Recombinant Human Interleukin-12 Subunit β/IL-12 p40/IL-12B
Sign In for Pricing
View Details 
orb1648345-03 500 µg
Recombinant Human Interleukin-12 Subunit β/IL-12 p40/IL-12B
Sign In for Pricing
View Details 
orb1648345-04 1 mg
Recombinant Human Interleukin-12 Subunit β/IL-12 p40/IL-12B
Sign In for Pricing
View Details